CD8A and neoplasm: Recent studies have further confirmed that Tregs and M2-type macrophages together constitute key immunosuppressive hubs within the TME, which collectively attenuate the effector functions of infiltrating CD8+ T cells and other antitumor immune cells, thereby inhibiting tumor cell killing and limiting the efficacy of immune-based therapies (38–40).